Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Neose Technologies, Inc. (NASDAQ: NTEC) Delayed: 9.63 --0 (-0%)
Previous Close $9.63    52 Week High $6.36 
Open $129.86    52 Week Low $3.03 
Day High $9.63    P/E N/A 
Day Low $9.63    EPS $0.00 
Volume 282,816       

Neose Technologies, Inc. (NASDAQ: NTEC) Delayed: 9.63 --0 (-0%)
Previous Close $9.63    52 Week High $6.36 
Open $129.86    52 Week Low $3.03 
Day High $9.63    P/E N/A 
Day Low $9.63    EPS $0.00 
Volume 282,816